Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01444092 · ClinicalTrials.gov registry record · Phase 3
Safety Study of Entocort for Children With Crohn's Disease
A Phase 3 study, sponsored by Padagis.
- Completed
- Registry status
- Phase 3
- Development phase
- 123
- Enrollment target
NCT01444092: Completed Phase 3 study, sponsored by Padagis.
NCT01444092 is a Phase 3 study that has completed, run by Padagis. The registered enrollment target is 123 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01444092, a Phase 3 study, has completed, sponsored by Padagis.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 123 participants
- Enrollment target
Study Summary
A Safety Study using Entocort EC for children with mild to moderate Crohn's Disease
Primary Outcome
Number of patients with at least one adverse event
Interventions
- DRUG Entocort
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2011-11 |
| Est. Completion | 2014-09 |
| Phase | Phase 3 |
What the finished NCT01444092 record still lists
NCT01444092 is an interventional study that assigns participants to a tested intervention. The registered 123 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (84% lower).
The record links to 0 conditions, and to 1 intervention - of which Entocort is the first listed.
NCT01444092 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01444092 about?
NCT01444092 is a clinical study titled "Safety Study of Entocort for Children With Crohn's Disease". A Safety Study using Entocort EC for children with mild to moderate Crohn's Disease
What is the current status of trial NCT01444092?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 123 participants. The study started on 2011-11. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01444092?
The interventions under investigation include: Entocort (DRUG).
Who is sponsoring clinical trial NCT01444092?
This trial is sponsored by Padagis, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01444092's enrollment target sits among peer trials
123 1615th of 2000 higher than 384 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05285891 · 123 participants · Phase 4
Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
- NCT05334368 · 123 participants · Phase 3
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
- NCT06088355 · 123 participants · NA
Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease
- NCT06111131 · 123 participants · NA
Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia